Company Profile
Updated: 29-SEP-09GlycoGenesys Inc.
Public Company, Headquarters Location
31 St. James Ave, 8th Fl., Boston, MA 02116-4101, United States
(800)260-6843, (617)422-0674, (617)422-0675 fax,
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Novel pharmaceutical products based on carbohydrate compounds.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Appointments And Advancements.
BIOWORLD Today; 11/4/2009; 873 words; ...president, sales. Endo Pharmaceuticals Inc., of Chadds Ford, Pa., named...operating officer. EraGen Biosciences Inc., of Madison, Wis., appointed...marketing and corporate communications. GlycoGenesys Inc., of Boston, added Philip Kantoff...
Other News To Note.
BIOWORLD Today; 11/3/2009; 2565 words; ...antagonist technologies to Genentech Inc., of South San Francisco. Abnormal...June 12, 2003.) o CV Therapeutics Inc., of Palo Alto, Calif., intends...medicinal chemistry agreement. o GlycoGenesys Inc., of Boston, began a Phase I dose...
Pro-Pharmaceuticals Prevails in Trade Secret Lawsuit.
Business Wire; 7/17/2009; 1302 words; ...prosecuted by Prospect Therapeutics, Inc. ("Prospect") against the...Officer, Pro-Pharmaceuticals, Inc. We believe the termination...According to Pro-Pharmaceuticals, Inc., Prospect purchased certain...including this lawsuit, from the GlycoGenesys bankruptcy estate and continued...
Research and Markets: Cytotoxic Therapies, Camptosar, Eloxatin and Xeloda Are Some of the Product Segments Analyzed Inside the 2006 Global Strategic Business Report On Colorectal Cancer (CRC) Therapeutics.
Business Wire; 12/1/2006; 1043 words; ...Inc (Canada) - Genentech, Inc (USA) - Genvec, Inc (USA) - Genzyme Corporation (USA) - Glaxosmithkline PLC (UK) - GlaxoSmithKline, Inc (USA) - Glycogenesys, Inc (USA) - Idera Pharmaceuticals, Inc (USA) - IDM...
A DRUG ADRIFT
The Boston Globe; 8/22/2006; 788 words; ...company that owned it, Glycogenesys Inc., in the fall of 1999...litigation. In the end, Glycogenesys had the compound, but...rights. They still do. Glycogenesys ran out of money before...Research and Development Inc., and filed in US...
Recent News Articles
- GlycoGenesys, Inc. Announces Chapter 11 Filing, Reduction in Work Force and Senior Management Changes.
PR Newswire - February 03, 2006 - GlycoGenesys, Inc. Requests Hearing to Appeal Nasdaq Staff Determination.
Business Wire - January 04, 2006 - GlycoGenesys, Inc. GCS-100 Cancer Drug Candidate Subject of Abstract in The American Society of Hematology's Annual Meeting Abstracts Book.
Business Wire - December 15, 2005 - GlycoGenesys, Inc. Comments on 2005 Third Quarter Financial Results and Stock Listing Status; Quarterly Conference Call Scheduled for December 12, 2005.
Business Wire - November 23, 2005
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning